Mode
Text Size
Log in / Sign up

vilanterol

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of vilanterol

8 trials tracked of vilanterol: 7 in phase 3 or 4 and 3 with published results. The most-cited published study has 50 citations.

8Trials tracked
7Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 1 Phase 3 6 Phase 2 1
  1. Phase 3 Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease Completed · 50 cited
  2. Phase 3 Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Completed · 38 cited
  3. Phase 3 A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma Completed · 21 cited
  4. Phase 4 Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD). Completed
  5. Phase 3 RELOVAIR® Lung Deflation Study Completed
  6. Phase 3 Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma Completed
Show 2 more trials
  1. Phase 3 A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD Completed
  2. Phase 2 Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.